Addex Therapeutics Ltd (ADXN)

Currency in USD
7.5401
-1.0499(-12.22%)
Closed·
After Hours
8.0000+0.4599(+6.0994%)
·
ADXN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual Post-Market activity
Fair Value
Day's Range
7.54008.7100
52 wk Range
6.510013.2700
Key Statistics
Prev. Close
8.59
Open
8.71
Day's Range
7.54-8.71
52 wk Range
6.51-13.27
Volume
3.4K
Average Volume (3m)
7.37K
1-Year Change
-5.87%
Book Value / Share
0.1
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ADXN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Addex Therapeutics Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Addex Therapeutics Company Profile

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson’s disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM); and GABAB PAM for the treatment pain, anxiety, addiction, cough, and overactive bladder. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the develop mGlu2 PAM compounds for the treatment of human health; and license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.

Addex Therapeutics Ltd Earnings Call Summary for Q1/2025

  • Q1 2025 income dropped to $100,000 from $200,000 in Q1 2024; cash reserves at CHF 2.8 million, sufficient until mid-2026
  • Significant progress in drug development, particularly GABA B PAM program; stock up 1.05% in premarket trading
  • Company anticipates IND-enabling studies for chronic cough program and clinical pharmacology studies for dipaglutide
  • CEO optimistic about dipaglutide's potential as first-in-class drug for stroke recovery; exploring partnership opportunities
  • Challenges include decreased revenue, competitive landscape in chronic cough market, and potential funding constraints for program development
Last Updated: 19-06-2025, 08:26 pm
Read Full Transcript

Compare ADXN to Peers and Sector

Metrics to compare
ADXN
Peers
Sector
Relationship
P/E Ratio
−1.0x8.9x−0.5x
PEG Ratio
−0.010.020.00
Price/Book
0.7x2.8x2.6x
Price / LTM Sales
24.0x2.4x3.2x
Upside (Analyst Target)
249.2%34.7%44.6%
Fair Value Upside
Unlock0.9%6.5%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
1.51K / --
EPS Revisions
Last 90 days

ADXN Income Statement

FAQ

What Is the Addex Therapeutics (ADXN) Stock Price Today?

The Addex Therapeutics stock price today is 7.54.

What Stock Exchange Does Addex Therapeutics Trade On?

Addex Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Addex Therapeutics?

The stock symbol for Addex Therapeutics is "ADXN."

What Is the Addex Therapeutics Market Cap?

As of today, Addex Therapeutics market cap is 7.36M.

What Is Addex Therapeutics's Earnings Per Share (TTM)?

The Addex Therapeutics EPS (TTM) is -0.06.

From a Technical Analysis Perspective, Is ADXN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Addex Therapeutics Stock Split?

Addex Therapeutics has split 1 times.

How Many Employees Does Addex Therapeutics Have?

Addex Therapeutics has 2 employees.

What is the current trading status of Addex Therapeutics (ADXN)?

As of 19 Jul 2025, Addex Therapeutics (ADXN) is trading at a price of 7.54, with a previous close of 8.59. The stock has fluctuated within a day range of 7.54 to 8.71, while its 52-week range spans from 6.51 to 13.27.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.